Effect of growth of Walker 256 carcinosarcoma of the fibrinolytic system of the rat plasma and urine.
作者信息
Mootse G, Agostino D, Cliffton E E
出版信息
Tumori. 1970 Mar-Apr;56(2):71-81. doi: 10.1177/030089167005600201.
PMID:4248380
Abstract
摘要
相似文献
1
Walker 256癌肉瘤生长对大鼠血浆和尿液纤溶系统的影响。
Tumori. 1970 Mar-Apr;56(2):71-81. doi: 10.1177/030089167005600201.
2
肾小球肾炎患者蛋白质与纤维蛋白溶解的研究
Br Med J. 1970 May 2;2(5704):260-3. doi: 10.1136/bmj.2.5704.260.
3
The physiology of fibrinolysis.
Med Clin North Am. 1972 Jan;56(1):153-62. doi: 10.1016/s0025-7125(16)32431-2.
4
Inhibitory effect of normal and cancerous tissues of the bladder on plasminogen activation.
Invest Urol. 1973 Nov;11(3):258-62.
5
[人血浆纤维蛋白溶解中的前激活剂-激活剂系统：关于从人血浆中分离出的由功能纯的纤维蛋白原、纤溶酶原和前激活剂组成的合成纤维蛋白溶解系统的研究]
Nihon Seirigaku Zasshi. 1972 Mar;34(3):147-55.
6
Trypsin inhibitor excretion due to fibrinolytic activation of cat plasma.
Proc Soc Exp Biol Med. 1968 Oct;129(1):70-3. doi: 10.3181/00379727-129-33252.
7
[Fibrinolytic activity in Behçet's disease].
Nippon Ganka Gakkai Zasshi. 1972 Mar;76(3):114-21.
8
体内纤溶成分的摩尔浓度，尤其是游离纤溶酶。
Thromb Diath Haemorrh. 1975 Apr 30;33(2):244-55.
9
Studies on plasminogen activators. II. A method for the separation of purified urokinase from small samples of urine.
Acta Chem Scand. 1966;20(9):2551-8. doi: 10.3891/acta.chem.scand.20-2551.
10
Biochemical pharmacology of the fibrinolysin system of the rat. I. The effect of alloxan-induced hyperglycemia.
J Pharmacol Exp Ther. 1974 May;189(2):317-26.
Zotero 插件